- Lobbying
- Lobbying by Pharmaceutical Research and Manufacturers of America (PhRMA)
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Joel Johnson | Chief of Staff, Senator Howard Metzenbaum Exec. Director, House Democratic Study Group Assistant Secretary of the Minority, U.S. Senate Staff Director, Democrat Leadership Committees Special Assistant to the President for Policy and Comm. |
Mary Ann Chaffee | n/a |
Kimberly James | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Registration
Termination
Q4 Report
Q3 Report
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Registration
Issue(s) they said they’d lobby about: Legislative monitoring of prescription drug issues.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate